← Back to Clinical Trials
Recruiting NCT06205875

High Versus Low Dose Serratus Anterior Plane Block After Minimally Invasive Valve Surgery.

Trial Parameters

Condition Analgesia
Sponsor Jessa Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-02-21
Completion 2027-12-31
Interventions
High dose serratus anterior plane block (2.4 mg/kg patient ideal body weight)Low dose serratus anterior plane block (1.2mg/kg patient ideal body weight)PCIA with morphine

Brief Summary

This study aims to compare the efficacy and quality of pain relief provided by the high-dose serratus anterior plane (SAP) block with the standard SAP block in preventing and treating acute postoperative pain after total endoscopic aortic or mitral valve surgery.

Eligibility Criteria

Inclusion Criteria: * Scheduled for elective aortic valve surgery or elective mitral valve surgery via right anterolateral thoracotomy * Adult patients (minimally 18 years old) * Bodyweight \> 50kg * EuroScore ii \< 3% Exclusion Criteria: * Refusal to participate * Inability to communicate due to language or neurologic barriers * Inability to control and self-administer opioids with PCIA or to comprehend the NRS pain score due to confusion or learning difficulties * Chronic use of opioids * Chronic use of analgesic antidepressants and/or antiepileptics * Use of prohibited medication which possibly interacts with bupivacaine-epinephrine or opioids (mexiletine, ketoconazole, theophylline, IMAO, Digitalis and cimetidine) * History of major trauma or surgery to right chest wall * History of chronic pain at right chest wall * Allergy to opioids and/or local anesthetics * Allergy to paracetamol * Class 3 obesity (BMI 40 or more) * Pregnancy * Intraoperative events compromising early postoper

Related Trials